1. Home
  2. FIHL vs AMPH Comparison

FIHL vs AMPH Comparison

Compare FIHL & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FIHL
  • AMPH
  • Stock Information
  • Founded
  • FIHL 2014
  • AMPH 1996
  • Country
  • FIHL Bermuda
  • AMPH United States
  • Employees
  • FIHL N/A
  • AMPH N/A
  • Industry
  • FIHL
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • FIHL
  • AMPH Health Care
  • Exchange
  • FIHL Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • FIHL 1.8B
  • AMPH 1.1B
  • IPO Year
  • FIHL 2023
  • AMPH 2014
  • Fundamental
  • Price
  • FIHL $16.58
  • AMPH $23.18
  • Analyst Decision
  • FIHL Hold
  • AMPH Hold
  • Analyst Count
  • FIHL 7
  • AMPH 5
  • Target Price
  • FIHL $20.14
  • AMPH $38.00
  • AVG Volume (30 Days)
  • FIHL 826.8K
  • AMPH 507.4K
  • Earning Date
  • FIHL 08-13-2025
  • AMPH 08-06-2025
  • Dividend Yield
  • FIHL 2.40%
  • AMPH N/A
  • EPS Growth
  • FIHL N/A
  • AMPH N/A
  • EPS
  • FIHL N/A
  • AMPH 2.77
  • Revenue
  • FIHL $2,558,400,000.00
  • AMPH $730,659,000.00
  • Revenue This Year
  • FIHL $24.21
  • AMPH $0.67
  • Revenue Next Year
  • FIHL $5.09
  • AMPH $5.18
  • P/E Ratio
  • FIHL N/A
  • AMPH $8.26
  • Revenue Growth
  • FIHL 23.93
  • AMPH 8.05
  • 52 Week Low
  • FIHL $14.17
  • AMPH $22.64
  • 52 Week High
  • FIHL $21.32
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • FIHL 46.40
  • AMPH 33.77
  • Support Level
  • FIHL $15.60
  • AMPH $24.35
  • Resistance Level
  • FIHL $16.39
  • AMPH $25.04
  • Average True Range (ATR)
  • FIHL 0.48
  • AMPH 0.72
  • MACD
  • FIHL -0.11
  • AMPH -0.33
  • Stochastic Oscillator
  • FIHL 32.36
  • AMPH 3.43

About FIHL Fidelis Insurance Holdings Limited

Fidelis Insurance Holdings Ltd is a specialty insurer that leverages strategic partnerships to offer tailored insurance solutions. The company classifies its business into two segments, Insurance and Reinsurance. A majority of its revenue is generated from the Insurance segment, which comprises a portfolio of property, marine, aviation and aerospace, political risk, violence and terror, energy, cyber, and other insurance risks. The Reinsurance segment consists of an actively managed property reinsurance book, providing reinsurance and a limited amount of retrocession coverage across the world on a proportional or excess-of-loss basis. Geographically, the company derives its key revenue from the United Kingdom, followed by Bermuda and the Republic of Ireland.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: